Literature DB >> 16014339

Levetiracetam for the treatment of generalized dystonia.

Kelly L Sullivan1, Robert A Hauser, Elan D Louis, Ganesh Chari, Theresa A Zesiewicz.   

Abstract

We report the case of a woman with generalized dystonia whose symptoms improved with the use of levetiracetam. Improvements were noted in blepharospasm, cervical, and truncal dystonia. The patient has been on LEV for a total of 20 weeks, and has experienced sustained improvement of symptoms.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16014339     DOI： 10.1016/j.parkreldis.2005.05.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


  5 in total

1.  Treatment of generalized dystonia.

Authors:  Naomi Lubarr; Susan Bressman
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

Review 2.  The neurobiological basis for novel experimental therapeutics in dystonia.

Authors:  Anthony M Downs; Kaitlyn M Roman; Simone A Campbell; Antonio Pisani; Ellen J Hess; Paola Bonsi
Journal:  Neurobiol Dis       Date:  2019-07-04       Impact factor: 5.996

3.  Current and future medical treatment in primary dystonia.

Authors:  Cathérine C S Delnooz; Bart P C van de Warrenburg
Journal:  Ther Adv Neurol Disord       Date:  2012-07       Impact factor: 6.570

4.  Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam.

Authors:  Varun Sreenivasan; Arkadiusz Z Dudek
Journal:  Case Rep Oncol       Date:  2013-01-30

5.  Does Levetiracetam Administration Prevent Cardiac Damage in Adulthood Rats Following Neonatal Hypoxia/Ischemia-Induced Brain Injury?

Authors:  Serkan Gurgul; Belgin Buyukakilli; Mustafa Komur; Cetin Okuyaz; Ebru Balli; Tuba Ozcan
Journal:  Medicina (Kaunas)       Date:  2018-04-10       Impact factor: 2.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.